Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Tissue Fibrosis and Repair: Mechanisms, Human Disease and Therapies (2022Z4)
Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches (2020Q6)
The Resolution of Inflammation in Health and Disease (2018C6)
Injury, Inflammation and Fibrosis (2017C8)
Fibrosis: From Basic Mechanisms to Targeted Therapies (2016Q3)
Fibrosis: From Bench to Bedside (2014C4)
Fibrosis: Translation of Basic Research to Human Disease and Novel Therapeutics (2012D1)

Web Desc
Fibrosis joint with Allergy and Asthma Organizer(s): John Varga, Thomas A. Wynn and Shelia Violette Date: January 20 - 25, 2009 Location: Keystone Resort, Keystone, CO, USA Sponsored by Genzyme Corporation For important information on the coronavirus, please click here Summary of Meeting: Fibrosis is a major cause of morbidity worldwide, can affect nearly all tissues, and is a dominant feature of diseases ranging from pulmonary fibrosis to glomerulosclerosis and cancer. Current treatments targeting the inflammatory cascade are ineffective in fibrosis. On-going research focuses on the role of innate immunity, and intrinsic mesenchymal cell alterations, plasticity, and progenitor cell differentiation in the pathogenesis. Experimental models, genetics and functional genomics have uncovered novel aspects of fibrosis, and innovative therapies are entering clinical trials. However, consensus on robust outcome measures or appropriate biomarkers for evaluating therapeutic effectiveness is lacking. This meeting brings together academic clinicians, researchers and pharmaceutical industry representatives from a variety of fields (1) to identify themes shared among the different fibrosing disorders, (2) to delineate promising novel molecular and cellular targets and treatment strategies, and (3) to discuss outcome measures and biomarkers for clinical trials. Opportunities for interdisciplinary interactions will be further enhanced by the concurrent meeting “Allergy and Asthma”, which will share a session with this meeting. Scholarship Deadline: September 22 2008 Discounted Abstract Deadline: September 22 2008 Abstract Deadline: October 22 2008 Discounted Registration Deadline: November 20 2008 We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: Genzyme Corporation KineMed, Inc. Promedior, Inc. Stromedix, Inc. We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

Fibrosis

joint with Allergy and Asthma

Organizer(s): John Varga, Thomas A. Wynn and Shelia Violette

Date: January 20 - 25, 2009
Location: Keystone Resort, Keystone, CO, USA

Program


Tuesday, January 20 \| 3:00PM - 7:30PM Registration Room: Longs Peak Foyer
Tuesday, January 20 \| 6:30PM - 7:30PM Refreshments Room: Longs Peak Foyer
Tuesday, January 20 \| 7:30PM - 8:30PM Keynote Address Room: Longs Peak Speaker 1 of 1 Harry (Hal) C. Dietz, Johns Hopkins University School of Medicine, Blade Therapeutics, USA TGF-beta, Microfibrils and Connective Tissue Homeostasis
Wednesday, January 21 \| 7:00AM - 8:00AM Breakfast Room: Quandary 1-3
Wednesday, January 21 \| 8:00AM - 11:15AM Cellular Basis of Fibrosis: Focus on the Lung Room: Longs Peak Speaker 1 of 7 * Moises Selman, Instituto Nacional de Enfermedades Respiratorias, Mexico
Wednesday, January 21 \| 8:00AM - 11:15AM Cellular Basis of Fibrosis: Focus on the Lung Room: Longs Peak Speaker 2 of 7 David A. Schwartz, University of Colorado Denver, USA Common Variants of MUC5AC and Pulmonary Fibrosis
Wednesday, January 21 \| 8:00AM - 11:15AM Cellular Basis of Fibrosis: Focus on the Lung Room: Longs Peak Speaker 3 of 7 Richard P. Phipps, University of Rochester, USA Fibroblast Heterogeneity –Impact of Fibroblast Diversity and Differentiation
Wednesday, January 21 \| 8:00AM - 11:15AM Cellular Basis of Fibrosis: Focus on the Lung Room: Longs Peak Speaker 4 of 7 Harold A. Chapman, University of California, San Francisco, USA Regulation of EMT and Pulmonary Fibrosis by Epithelial Integrins
Wednesday, January 21 \| 8:00AM - 11:15AM Cellular Basis of Fibrosis: Focus on the Lung Room: Longs Peak Speaker 5 of 7 Manuela Funke, Massachusetts General Hospital, USA Short Talk: Lysophosphatidic Acid Contributes to an Apoptosis Paradox in Lung Fibrosis
Wednesday, January 21 \| 8:00AM - 11:15AM Cellular Basis of Fibrosis: Focus on the Lung Room: Longs Peak Speaker 6 of 7 Boris Hinz, University of Toronto, Canada Myofibroblasts and Mechanical Signal Transduction
Wednesday, January 21 \| 8:00AM - 11:15AM Cellular Basis of Fibrosis: Focus on the Lung Room: Longs Peak Speaker 7 of 7 Usamah S. Kayyali, Tufts Medical Center, USA Short Talk: MK2 Signaling in Fibroblast Biology and Pulmonary Fibrosis
Wednesday, January 21 \| 8:00AM - 11:15AM Risk Factors, Early Life Events and Innate Mechanisms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 7 * Catherine M. Hawrylowicz, King's College London, UK
Wednesday, January 21 \| 8:00AM - 11:15AM Risk Factors, Early Life Events and Innate Mechanisms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 7 Marsha Wills-Karp, Johns Hopkins Bloomberg School of Public Health, USA Innate Immune Responses To Allergens
Wednesday, January 21 \| 8:00AM - 11:15AM Risk Factors, Early Life Events and Innate Mechanisms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 7 Patrick G. Holt, University of Western Australia, Australia Early Life Events that Influence Allergic Status
Wednesday, January 21 \| 8:00AM - 11:15AM Risk Factors, Early Life Events and Innate Mechanisms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 7 René Teich, Philipps University of Marburg, Germany Short Talk: Epigenetic Regulation of Asthma Protection Early in Life by the Non-Pathogenic Microbe Acinetobacter lwoffii F78
Wednesday, January 21 \| 8:00AM - 11:15AM Risk Factors, Early Life Events and Innate Mechanisms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 7 * Scott T. Weiss, Brigham and Women's Hospital, USA Vitamin D and Allergy/Asthma Prevalence
Wednesday, January 21 \| 8:00AM - 11:15AM Risk Factors, Early Life Events and Innate Mechanisms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 6 of 7 David B. Lewis, Stanford University, USA Influence of viral infections on the development of asthma: Insights from a murine model of influenza A viral-induced allergen sensitization for allergic pathogenesis and its prevention by vaccination for influenza
Wednesday, January 21 \| 8:00AM - 11:15AM Risk Factors, Early Life Events and Innate Mechanisms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 7 of 7 Matthew E. Poynter, University of Vermont, USA Short Talk: Airway Epithelial Activation of NF-kappaB is Sufficient to Promote Allergic Sensitization to an Innocuous Inhaled Antigen
Wednesday, January 21 \| 9:20AM - 9:40AM Coffee Break Room: Longs Peak Foyer
Wednesday, January 21 \| 11:15AM - 11:15AM On Own for Lunch
Wednesday, January 21 \| 11:15AM - 1:00PM Poster Setup Room: Quandary 1-3
Wednesday, January 21 \| 1:00PM - 10:00PM Poster Viewing Room: Quandary 1-3
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 1 of 9 * Richard H. Gomer, Texas A&M University, USA
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 2 of 9 * Robert Lafyatis, University of Pittsburgh Medical Center, USA
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 3 of 9 Brandi Nicole Baird, MD Anderson Cancer Center, Houston, TX, USA Identification and Characterization of Prospectively Isolated Candidate Stem/Progenitor Cells in the Adult Mouse Lung
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 4 of 9 Marianne E. Fairclough, University of Birmingham, UK Diversity within Monocyte Derived Stromal Cells
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 5 of 9 Darrell Pilling, Texas A&M University, USA Th-1 Cytokines Inhibit, and Th-2 Cytokines Promote Fibrocyte Differentiation
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 6 of 9 Kirkwood A. Pritchard Jr., Medical College of Wisconsin, USA The Role of Matrix and Mesenchymal Transition in Fibrosis in Tight Skin Mice
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 7 of 9 Peter H. S. Sporn, Northwestern University Feinberg School of Medicine, USA Epithelial-Mesenchymal Transition in Normal Human Bronchial Epithelial Cells Triggered by TGF-beta1, Eosinophils and Cyclic Mechanical Strain
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 8 of 9 Shangxi Liu, University of Western Ontario, Canada Loss of Beta 1 Integrin in Mouse Fibroblasts Results in Resistance to a bleo model of Skin Sclerodermav
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: EMT, Plasticity and the Origin of Fibroblasts Room: Longs Peak Speaker 9 of 9 Gregory deHart, FibroGen, Inc., USA Regulation of Epithelial to Mesenchymal Transition by Connective Tissue Growth Factor
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 8 * Marsha Wills-Karp, Johns Hopkins Bloomberg School of Public Health, USA
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 8 * Donata Vercelli, University of Arizona, USA Epigenetic Signatures of Environmental Exposures
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 8 Ulus Atasoy, University of Michigan, USA Coordinate Posttranscriptional Regulation of Asthma Genes by the RNA Binding Protein HuR
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 8 Annerose Berndt, University of Pittsburgh Medical Center, USA Haplotype Association Mapping for Airway Hyper-responsiveness and a Systematic Gene-identification Approach Identifies SERPINB6b
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 8 Jennifer Kearley, MedImmune, USA Chitinase-like Protein BRP-39 is a Critical Mediator of Allergic Sensitization
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 6 of 8 Benjamin D. Medoff, Massachusetts General Hospital, USA Adiponectin-Deficiency Increases Allergic Airway Inflammation and Pulmonary Vascular Remodeling
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 7 of 8 Lisa Cameron, University of Alberta, Canada CRTh2+1431G>C is Associated with sIgE to Food Allergens and Allele-specific Transcription Factor Binding
Wednesday, January 21 \| 2:30PM - 4:30PM Workshop 1: Genes and Gene: Environment Interactions and Inn ate Immunity This session is from Allergy and Asthma Room: Grays 1-3 Speaker 8 of 8 Sean Saunders, Trinity Institute of Biomedical Sciences, Ireland Talk Title to be Announced
Wednesday, January 21 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Wednesday, January 21 \| 5:00PM - 7:00PM Liver Fibrosis Room: Longs Peak Speaker 1 of 5 * Thomas A. Wynn, Pfizer, USA
Wednesday, January 21 \| 5:00PM - 7:00PM Liver Fibrosis Room: Longs Peak Speaker 2 of 5 Anna Mae Diehl, Duke University, USA The Cellular Biology and Clinical Spectrum of Liver Fibrosis
Wednesday, January 21 \| 5:00PM - 7:00PM Liver Fibrosis Room: Longs Peak Speaker 3 of 5 John P. Iredale, University of Bristol, UK Liver Fibrosis: A Dynamic Model of Inflammation and Repair
Wednesday, January 21 \| 5:00PM - 7:00PM Liver Fibrosis Room: Longs Peak Speaker 4 of 5 Margaret M. Mentink-Kane, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA Short Talk: Accelerated Liver Fibrosis in the Combined Absence of Interleukin-13 Regulatory Molecules: IL-13 Receptor Alpha 2, IL-10 and IL-12
Wednesday, January 21 \| 5:00PM - 7:00PM Liver Fibrosis Room: Longs Peak Speaker 5 of 5 Scott L. Friedman, Icahn School of Medicine at Mount Sinai, USA Genetic Determinants of Fibrosis Progression
Wednesday, January 21 \| 5:00PM - 7:00PM Structural and Resident Cells of the Lung This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 5 * Stephen J. Galli, Stanford University, USA
Wednesday, January 21 \| 5:00PM - 7:00PM Structural and Resident Cells of the Lung This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 5 * Michael J. Holtzman, Washington University in St. Louis, USA New Immune Pathways for Allergy and Asthma
Wednesday, January 21 \| 5:00PM - 7:00PM Structural and Resident Cells of the Lung This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 5 Hamida Hammad, Ghent University & VIB, Belgium Short Talk: TLR4 Expression on Airway Stromal Cells is Crucial for Innate and Adaptive Immunity to House Dust Mite Allergen
Wednesday, January 21 \| 5:00PM - 7:00PM Structural and Resident Cells of the Lung This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 5 Maria do Carmo Leite-de-Moraes, CNRS, University Paris 5, France NKT Cells in the Lung
Wednesday, January 21 \| 5:00PM - 7:00PM Structural and Resident Cells of the Lung This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 5 Steven F. Ziegler, Benaroya Research Institute, USA TSLP and Allergic Inflammation
Wednesday, January 21 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Quandary 1-3
Wednesday, January 21 \| 7:30PM - 10:00PM Poster Session 1 Room: Quandary 1-3
Thursday, January 22 \| 7:00AM - 8:00AM Breakfast Room: Quandary 1-3
Thursday, January 22 \| 8:00AM - 11:15AM The Immunology and Cell Biology of Fibrosis Room: Longs Peak Speaker 1 of 7 * John Varga, Feinberg School of Medicine, USA
Thursday, January 22 \| 8:00AM - 11:15AM The Immunology and Cell Biology of Fibrosis Room: Longs Peak Speaker 2 of 7 Thomas A. Wynn, Pfizer, USA Targets of IL-13 Signaling in Inflammation and Fibrosis
Thursday, January 22 \| 8:00AM - 11:15AM The Immunology and Cell Biology of Fibrosis Room: Longs Peak Speaker 3 of 7 Erica Herzog, Yale University School of Medicine, USA Short Talk: Profibrotic Monocyte Subsets in Pulmonary Fibrosis
Thursday, January 22 \| 8:00AM - 11:15AM The Immunology and Cell Biology of Fibrosis Room: Longs Peak Speaker 4 of 7 Rebecca G. Wells, University of Pennsylvania, USA Liver Fibrosis: The Intersection of Soluble and Mechanical Factors
Thursday, January 22 \| 8:00AM - 11:15AM The Immunology and Cell Biology of Fibrosis Room: Longs Peak Speaker 5 of 7 Paul W. Noble, Cedars-Sinai Medical Center, USA Regulation and Lung Injury and Repair: Toll Like Receptors and Innate Immunity
Thursday, January 22 \| 8:00AM - 11:15AM The Immunology and Cell Biology of Fibrosis Room: Longs Peak Speaker 6 of 7 Anna P. Lam, Northwestern University, USA Short Talk: Activated Canonical Wnt/beta-catenin Signaling Mediates Lung Fibroblast Migration and Proliferation
Thursday, January 22 \| 8:00AM - 11:15AM The Immunology and Cell Biology of Fibrosis Room: Longs Peak Speaker 7 of 7 Victor J. Thannickal, University of Alabama at Birmingham, USA Apoptosis and Fibroblast Survival in Fibrogenesis
Thursday, January 22 \| 8:00AM - 11:15AM Effector Mechanisms and Cells This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 7 * Bart N. Lambrecht, VIB, Ghent University, Belgium
Thursday, January 22 \| 8:00AM - 11:15AM Effector Mechanisms and Cells This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 7 Sally Wenzel-Morganroth, University of Pittsburgh, USA Asthma Phenotypes: Are we Closing the Loop to Pathobiology?
Thursday, January 22 \| 8:00AM - 11:15AM Effector Mechanisms and Cells This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 7 Stephanie C. Eisenbarth, Yale University, USA The Role of Inflammasomes in Vaccination and Allergic Disease
Thursday, January 22 \| 8:00AM - 11:15AM Effector Mechanisms and Cells This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 7 Hiroshi Watarai, Riken Research Center for Allergy and Immunology, Japan Short Talk: A novel Subset of Mouse NKT Cells Bearing the IL-17 Receptor B Responds to IL-25 and Contributes to Airway Hyperreactivity
Thursday, January 22 \| 8:00AM - 11:15AM Effector Mechanisms and Cells This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 7 Frances E. Lund, University of Alabama at Birmingham, USA CD38: Modulator of the NAD Metabolome and Regulator of Inflammation
Thursday, January 22 \| 8:00AM - 11:15AM Effector Mechanisms and Cells This session is from Allergy and Asthma Room: Grays 1-3 Speaker 6 of 7 Pierre Bruhns, Institut Pasteur, France Short Talk: FcgammaRIV as a Murine Equivalent of FcepsilonRI Expressed by Macrophages from Human Atopics in IgE-Induced inflammation
Thursday, January 22 \| 8:00AM - 11:15AM Effector Mechanisms and Cells This session is from Allergy and Asthma Room: Grays 1-3 Speaker 7 of 7 * K. Frank Austen, Harvard Medical School, USA Leukotrienes as Therapeutic Targets in Asthma
Thursday, January 22 \| 9:20AM - 9:40AM Coffee Break Room: Longs Peak Foyer
Thursday, January 22 \| 11:15AM - 11:15AM On Own for Lunch
Thursday, January 22 \| 11:15AM - 1:00PM Poster Setup Room: Quandary 1-3
Thursday, January 22 \| 1:00PM - 10:00PM Poster Viewing Room: Quandary 1-3
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 1 of 8 * Andrew M. Tager, Massachusetts General Hospital, USA
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 2 of 8 * † John Westwick, Walden, UK
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 3 of 8 Shizhong Bu, Medical University of South Carolina, USA DhS1P has a Potent Anti-Fibrotic Effect in Scleroderma Fibroblasts via Modulation of PTEN Levels
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 4 of 8 Enrique Brandan, P. Universidad Católica de Chile, Chile Induction of Fibrosis by Exercise on Dystrophic Muscles: Role of CTGF
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 5 of 8 Tomoko Hayashida, Northwestern University, USA Lack of beta1 Integrin Enhances TGF-beta Stimulated Type I Collagen Synthesis via Rac1 Mediated ERK Activity that Phosphorylates Smad Linker Region
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 6 of 8 Andreas Günther, University Hospital Giessen, Germany Role of Defective Surfactant Processing and Transport in Hermansky-Pudlak-Syndrome Associated Interstitial Pneumonia (HPSIP) and Idiopathic Pulmonary Fibrosis (IPF)
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 7 of 8 Pura Muñoz Cánoves, Center for Genomic Regulation, Spain Fibrin-Induced Inflammation Promotes Fibrosis in Muscular Dystrophy
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Model Systems for Studying Fibrosis Room: Longs Peak Speaker 8 of 8 Joe (Jia-hui) Wang, King's College London, UK Antisense Inhibition of Kirsten-Ras Expression Reduces Fibrosis in a Rat Model of Unilateral Ureteric Obstruction
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 10 * Bart N. Lambrecht, VIB, Ghent University, Belgium
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 10 * Paul B. Rothman, University of Iowa, USA
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 10 Charlotte Andreasen, Yale University, USA TGF-beta1 Production by Alveolar Macrophages is Crucial for Controlling Inflammation in the Lung
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 10 Alison L. Budelsky, Janssen Pharmaceutical Companies of Johnson & Johnson, USA Investigation of the Functional Roles for IL-17A, IL-25, IL-17RA, and IL-17RB in a Mouse Asthma Model
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 10 Jennifer Louten, Schering-Plough Biopharma, USA IL-23 Signaling Negatively Regulates Th2 Responses in Asthma
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 6 of 10 Martijn C. Nawijn, University Medical Center Groningen, Netherlands PAR2 Activation Induces Airways Hyperresponsiveness without Loss of Inhalation Tolerance
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 7 of 10 Mindy Tsai, Stanford University, USA Thymic Stromal Lymphopoietin (TSLP) Promotes Myeloid Hyperplasia and Overproduction of Immunoglobulins, but not Skin Inflammation, in RabGEF1-deficient Mice
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 8 of 10 Nicolas Charles, INSERM U1149, France Homeostatic Control of Basophil GATA-3 Expression and TH2 Differentiation by Lyn Kinase
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 9 of 10 Wanjun Chen, NIDCR, National Institutes of Health, USA TGF-beta in the Development of CD4+ Foxp3+ Regulatory T Cells and the Regulation of House Dust Mite Induced Asthma
Thursday, January 22 \| 2:30PM - 4:30PM Workshop 2: Intercellular and Intracellular Signaling Mechan isms This session is from Allergy and Asthma Room: Grays 1-3 Speaker 10 of 10 Nandini Krishnamoorthy, Brigham and Women's Hospital, Harvard Medical School, USA A Critical Role for c-kit on Dendritic Cells in Regulating in T Helper Cell Differentiation and Allergic Asthma
Thursday, January 22 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Thursday, January 22 \| 5:00PM - 7:15PM Renal Fibrosis Room: Longs Peak Speaker 1 of 6 * Michael Zeisberg, Beth Israel Deaconess Medical Center and Harvard Medical School, USA
Thursday, January 22 \| 5:00PM - 7:15PM Renal Fibrosis Room: Longs Peak Speaker 2 of 6 Jeffrey B. Kopp, National Institutes of Health, USA Overview of Renal Fibrosis
Thursday, January 22 \| 5:00PM - 7:15PM Renal Fibrosis Room: Longs Peak Speaker 3 of 6 Agnes Fogo, Vanderbilt University Medical Center, USA Animal Models and the Reversibility of Fibrosis
Thursday, January 22 \| 5:00PM - 7:15PM Renal Fibrosis Room: Longs Peak Speaker 4 of 6 Jeremy S. Duffield, Vertex Pharmaceuticals, USA Short Talk: Serum Amyloid P inhibits Renal Fibrosis through an Fc-gamma receptor dependent mechanism.
Thursday, January 22 \| 5:00PM - 7:15PM Renal Fibrosis Room: Longs Peak Speaker 5 of 6 H. William Schnaper, Northwestern University, USA TGF-beta Signaling in Renal Fibrogenesis
Thursday, January 22 \| 5:00PM - 7:15PM Renal Fibrosis Room: Longs Peak Speaker 6 of 6 Jeremy S. Duffield, Vertex Pharmaceuticals, USA Short Talk: Genetic Fate tracing reveal the stromal pericyte not EMT Generates Myofibroblasts in the Obstructive Model of Kidney Fibrosis
Thursday, January 22 \| 5:00PM - 7:00PM Immune Regulation This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 5 * Steven F. Ziegler, Benaroya Research Institute, USA
Thursday, January 22 \| 5:00PM - 7:00PM Immune Regulation This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 5 Valerie Julia, Galderma, Switzerland Breast Milk-Mediated Transfer of an Antigen Induces Tolerance and Protection from Allergic Asthma
Thursday, January 22 \| 5:00PM - 7:00PM Immune Regulation This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 5 * Catherine M. Hawrylowicz, King's College London, UK Regulatory T Cells in Allergy and Asthma: The Role of the Vitamin D Pathway
Thursday, January 22 \| 5:00PM - 7:00PM Immune Regulation This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 5 Yong-Jun Liu, Sanofi, USA Cross Talk between Epithelial Cells and Dendritic Cells through TSLP/TSLPR in Allergic Inflamation
Thursday, January 22 \| 5:00PM - 7:00PM Immune Regulation This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 5 Hiromasa Inoue, Kagoshima University, Japan Short Talk: Pulmonary SOCS1 as a Central Endogenous Inhibitor of Allergic Asthma
Thursday, January 22 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Quandary 1-3
Thursday, January 22 \| 7:30PM - 10:00PM Poster Session 2 Room: Quandary 1-3
Friday, January 23 \| 7:00AM - 8:00AM Breakfast Room: Quandary 1-3
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 1 of 8 * Cory M. Hogaboam, Cedars-Sinai Medical Center, USA
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 2 of 8 Jack A. Elias, Yale School of Medicine, USA Insights from Transgenic Models of Lung Fibrosis
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 3 of 8 James J. Lee, Mayo Clinic Scottsdale, USA Eosinophils Orchestrate Allergic Pulmonary Responses: Who’s your Daddy Now T Cells!
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 4 of 8 John V. Fahy, University of California, San Francisco, USA Short Talk: Plasma Proteins Inhibit Protease-Dependent Degradation of Airway Mucus Plugs in Acute Asthma
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 5 of 8 Hajime Karasuyama, Tokyo Medical and Dental University, Graduate School, Japan Short Talk: Basophils Resolve Inflammation through Alternate Activation of Macrophages
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 6 of 8 Lauren E. Cohn, Yale University, USA Short Talk: IFN-gamma Modulates Allergic Airway Disease through Effects on the Airway Epithelium
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 7 of 8 Jean Kim, Johns Hopkins University School of Medicine, USA Short Talk: Involvement of VEGF in Upper Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyposis Subjects
Friday, January 23 \| 8:00AM - 11:15AM Asthma, Allergy and Tissue Remodeling (Joint) Room: Longs Peak / Grays Peak Speaker 8 of 8 Stephen J. Galli, Stanford University, USA Mast Cells and Tissue Remodeling
Friday, January 23 \| 9:20AM - 9:40AM Coffee Break Room: Longs Peak Foyer
Friday, January 23 \| 11:15AM - 11:15AM On Own for Lunch
Friday, January 23 \| 11:15AM - 1:00PM Poster Setup Room: Quandary 1-3
Friday, January 23 \| 1:00PM - 10:00PM Poster Viewing Room: Quandary 1-3
Friday, January 23 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Friday, January 23 \| 5:00PM - 7:15PM Environmental Cues and Cellular Responses Room: Longs Peak Speaker 1 of 6 Rik Derynck, University of California, San Francisco, USA TGF-beta Signaling and Epithelial to Mesenchymal Transition
Friday, January 23 \| 5:00PM - 7:15PM Environmental Cues and Cellular Responses Room: Longs Peak Speaker 2 of 6 Florian Rieder, Cleveland Clinic, USA Short Talk: Endothelial-to-Mesenchymal Transition of Intestinal Mucosal Microvascular Cells: A Novel Mechanism of Intestinal Fibrosis
Friday, January 23 \| 5:00PM - 7:15PM Environmental Cues and Cellular Responses Room: Longs Peak Speaker 3 of 6 Andrew D. Luster, Massachusetts General Hospital, USA Inflammation and Fibrosis - Chemokines, LPA
Friday, January 23 \| 5:00PM - 7:15PM Environmental Cues and Cellular Responses Room: Longs Peak Speaker 4 of 6 Andrew M. Tager, Massachusetts General Hospital, USA Grease on the Fire: Chemokine- Lipid cooperation in Fibrosis
Friday, January 23 \| 5:00PM - 7:15PM Environmental Cues and Cellular Responses Room: Longs Peak Speaker 5 of 6 * Luisa A. DiPietro, University of Illinois at Chicago, USA Scar Formation in the Healing Wound
Friday, January 23 \| 5:00PM - 7:15PM Environmental Cues and Cellular Responses Room: Longs Peak Speaker 6 of 6 Keith C. Olsen, University of Rochester, USA Short Talk: Tissue Transglutaminase as a Novel Modulator of and Potential Therapeutic Target in Pulmonary Fibrosis
Friday, January 23 \| 5:00PM - 7:00PM Lipid Mediators, Proteases and Cytokines in Tissue Remodelin g This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 5 * Joshua A. Boyce, Brigham and Women's Hospital, Harvard Medical School, USA
Friday, January 23 \| 5:00PM - 7:00PM Lipid Mediators, Proteases and Cytokines in Tissue Remodelin g This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 5 Clare M. Lloyd, Imperial College London, UK Cytokine Regulation of Allergic Airway Inflammation and Remodeling
Friday, January 23 \| 5:00PM - 7:00PM Lipid Mediators, Proteases and Cytokines in Tissue Remodelin g This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 5 * Juan Rivera, USA Sphingosine-1-Phosphate in Allergy and Asthma
Friday, January 23 \| 5:00PM - 7:00PM Lipid Mediators, Proteases and Cytokines in Tissue Remodelin g This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 5 Gunnar Pejler, Swedish University of Agricultural Sciences, Sweden Mast Cell Chymase - A Friend or Foe?
Friday, January 23 \| 5:00PM - 7:00PM Lipid Mediators, Proteases and Cytokines in Tissue Remodelin g This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 5 Cara MM Williams, Wyeth Pharmaceuticals, USA Short Talk: Cytosolic Phospholipase A2alpha Orchestrates Allergic Disease
Friday, January 23 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Quandary 1-3
Friday, January 23 \| 7:30PM - 10:00PM Poster Session 3 Room: Quandary 1-3
Saturday, January 24 \| 7:00AM - 8:00AM Breakfast Room: Quandary 1-3
Saturday, January 24 \| 8:00AM - 11:15AM Novel Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 1 of 7 * Michael Gilman, Arrakis Therapeutics, USA
Saturday, January 24 \| 8:00AM - 11:15AM Novel Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 2 of 7 Howard Y. Chang, Stanford University, USA Genomic Encoding of Fibroblast Positional Identities: Implications for Fibrosis
Saturday, January 24 \| 8:00AM - 11:15AM Novel Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 3 of 7 Roland M. duBois, National Jewish Health, USA Genetics of Diffuse Lung Fibrosis: Lessons Learned
Saturday, January 24 \| 8:00AM - 11:15AM Novel Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 4 of 7 Shelia M. Violette, Q32 Bio, USA Therapeutic Potential of a Function Blocking alphavbeta6 Antibody in Fibrosis and Oncology: Transition from Research to Clinic Development
Saturday, January 24 \| 8:00AM - 11:15AM Novel Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 5 of 7 Scott M. Lonning, Cell Signaling Technology, USA Prospects and Challenges of TGFbeta Neutralization for the Treatment of Pathologic Fibrosis
Saturday, January 24 \| 8:00AM - 11:15AM Novel Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 6 of 7 Francesco Del Galdo, Thomas Jefferson University, USA Short Talk: Quantitative Assessment of Tissue Fibrosis in Skin Biopsies from Patients with Systemic Sclerosis Employing Confocal Laser Scanning Microscopy (CLSM). An Objective Outcome Measure for Clinical Trials
Saturday, January 24 \| 8:00AM - 11:15AM Novel Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 7 of 7 Kusum V. Pandit, University of Pittsburgh, USA Short Talk: MicroRNAs in Lung Fibrosis
Saturday, January 24 \| 8:00AM - 11:00AM Conventional and Novel Targets for Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 7 * Edith M. Hessel, Dynavax Technologies, USA
Saturday, January 24 \| 8:00AM - 11:00AM Conventional and Novel Targets for Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 7 John A. Cidlowski, NIEHS, National Institutes of Health, USA The Glucocorticoid Receptor: One Gene, Many Proteins – New Mechanisms for Tissue Specific Anti-Inflammatory Actions of Glucocorticoids in Health and Disease.
Saturday, January 24 \| 8:00AM - 11:00AM Conventional and Novel Targets for Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 7 Marco Conti, University of California, San Francisco, USA Cyclic AMP-Specific Phosphodiesterase Regulation as a Critical Component of the Airway Inflammatory Responses
Saturday, January 24 \| 8:00AM - 11:00AM Conventional and Novel Targets for Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 7 Joshua A. Boyce, Brigham and Women's Hospital, Harvard Medical School, USA Short Talk: Leukotriene E4-Induced Pulmonary Inflammation is Mediated by the P2Y12 Receptor
Saturday, January 24 \| 8:00AM - 11:00AM Conventional and Novel Targets for Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 7 Heidi Campos Schilter, Pharmaxis, Australia Short Talk: A Role for Fatty Acid Binding Proteins in Airway Immune Responses
Saturday, January 24 \| 8:00AM - 11:00AM Conventional and Novel Targets for Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 6 of 7 Prescott G. Woodruff, University of California, San Francisco, USA Short Talk: Presence or Absence of IL-13-Driven Inflammation Defines Major Sub-Phenotypes of Asthma
Saturday, January 24 \| 8:00AM - 11:00AM Conventional and Novel Targets for Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 7 of 7 Monika Vig, Washington University School of Medicine, USA CRACM1, a Potential Target for Inhibition of Allergic and Inflammatory Disorders
Saturday, January 24 \| 9:20AM - 9:40AM Coffee Break Room: Longs Peak Foyer
Saturday, January 24 \| 11:15AM - 11:15AM On Own for Lunch
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 1 of 9 * Shelia M. Violette, Q32 Bio, USA
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 2 of 9 April A. Cox, Array Biopharma, USA Preclinical Efficacy of a PDGFR inhibitor, ARRY-768, in a Rat Model of Gadolinium-Induced Fibrosis
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 3 of 9 Francesco Del Galdo, Thomas Jefferson University, USA A Pattern of Shared Alterations in the Secretome of Dermal Fibroblasts from Systemic Sclerosis and Nephrogenic Systemic Fibrosis: A Biomarker Signature for Fibrotic Diseases
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 4 of 9 Qihe Xu, King's College London School of Medicine, UK Discovery of Herbal Compounds with in vitro Anti-Fibrotic Activities
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 5 of 9 Jadranka Milosevic, Simmons Center for Interstitial Lung Disease, USA The Role of miR-154 microRNA Family in IPF
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 6 of 9 Jennifer L. Sargent, Dartmouth Medical School, USA Overlapping and Distinct Gene Targets of TGFbeta, IL13 and IL4 in Dermal Fibroblasts are Expressed in Distinct Molecular Subsets of Systemic Sclerosis
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 7 of 9 Timothy W. Schacker, University of Minnesota, USA Lymph Node Fibrosis Is A Significant Factor In HIV Pathogenesis And Limits Immune Reconstitution Despite Antiretroviral Therapy Suppression of Viral Replication
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 8 of 9 Oscar O. Braun, University of California San Diego, USA Cyclic AMP can Both Block and Reverse the Fibrotic Phenotype of Cardiac Fibroblasts
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Therapeutic Targets and Biomarkers Room: Longs Peak Speaker 9 of 9 Guofei Zhou, Northwestern University, USA Elevated von Hippel-Lindau Protein Expression in Fibrotic Lungs and Its Role in Fibrogenesis
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 9 * Stephen J. Galli, Stanford University, USA
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 9 Helen E. Harries, UK Local Clonal Expansion of IgE Producing B Cells
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 9 Yuzaburo Inoue, Graduate School of Medicine, Chiba University, Japan Chitinase Family Members Inhibit House Dust Mite-Induced AHR Independently of Enzymatic Activity
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 9 Irene H. Heijink, University Medical Center Groningen, Netherlands House Dust Mite-Promoted Epithelial-to-Mesenchymal Transition in Human Bronchial Epithelium
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 9 Sara Wernersson, Swedish University of Agricultural Sciences, Sweden Protective Role of mMCP-4 in Allergic Inflammation
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 6 of 9 Mayumi Ueta, Kyoto Prefectural University of Medicine, Japan PGE Receptor Subtype EP3 Regulates LPR of Allergic Conjunctivitis
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 7 of 9 Karin Stebbins, Amira Pharmaceuticals, USA Novel DP2 Receptor Antagonist Decreases Allergic Inflammation
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 8 of 9 Anton J.M. van Oosterhout, GSK R&D, UK IL-10 Producing CD11c+ Cells in SIT in Mouse Model of Asthma
Saturday, January 24 \| 2:30PM - 4:30PM Workshop 3: Effector Cells and Mechanisms in Asthma This session is from Allergy and Asthma Room: Grays 1-3 Speaker 9 of 9 Joan M. Cook-Mills, Indiana University, USA Isoforms of Vitamin E have Opposing Immunoregulatory Function in Allergic Inflammation
Saturday, January 24 \| 4:30PM - 5:00PM Coffee Available Room: Longs Peak Foyer
Saturday, January 24 \| 5:00PM - 7:00PM Novel Therapies Room: Longs Peak Speaker 1 of 5 * Scott M. Lonning, Cell Signaling Technology, USA
Saturday, January 24 \| 5:00PM - 7:00PM Novel Therapies Room: Longs Peak Speaker 2 of 5 Bruce Cronstein, New York University, USA Venegeance is Mine. Adenosine, a Retaliatory Metabolite
Saturday, January 24 \| 5:00PM - 7:00PM Novel Therapies Room: Longs Peak Speaker 3 of 5 Mark L. Lupher, Jr., Muregen, LLC, USA Regulating Fibrosis with the Natural Innate Response Modifier, SAP
Saturday, January 24 \| 5:00PM - 7:00PM Novel Therapies Room: Longs Peak Speaker 4 of 5 Claire Emson, Genentech, Inc., USA Measurement of Collagen Synthesis by Heavy Water Labeling and its Application for Indentifying Anti-Fibrotic Therapies
Saturday, January 24 \| 5:00PM - 7:00PM Novel Therapies Room: Longs Peak Speaker 5 of 5 Ruchi Bansal, University of Twente, Netherlands Short Talk: A Mimetic Peptide of Interferon gamma (IFNgamma) as a Novel Anti-Fibrotic Agent
Saturday, January 24 \| 5:00PM - 7:00PM Immune Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 1 of 5 * Yong-Jun Liu, Sanofi, USA
Saturday, January 24 \| 5:00PM - 7:00PM Immune Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 2 of 5 Edith M. Hessel, Dynavax Technologies, USA Effects of TLR-9 Agonists in Asthma: Moving Towards Long-Lasting Disease Modification
Saturday, January 24 \| 5:00PM - 7:00PM Immune Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 3 of 5 Lawren C. Wu, Amgen Inc., USA Short Talk: Reduction of Serum IgE by Depletion of the IgE B Cell Lineage – a Novel Approach for the Treatment of Allergic Diseases
Saturday, January 24 \| 5:00PM - 7:00PM Immune Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 4 of 5 Bart N. Lambrecht, VIB, Ghent University, Belgium Targeting Dendritic Cells
Saturday, January 24 \| 5:00PM - 7:00PM Immune Intervention This session is from Allergy and Asthma Room: Grays 1-3 Speaker 5 of 5 * Anthony J. Coyle, Pfizer, USA Cytokine Antagonists
Saturday, January 24 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Quandary 1-3
Saturday, January 24 \| 8:00PM - 11:00PM Entertainment Room: Quandary 1-3
Saturday, January 24 \| 8:00PM - 11:00PM Cash Bar Room: Quandary 1-3
Sunday, January 25 \| 10:22AM - 10:22AM Departure *Session Chair †Invited, not yet responded.